Skip to main content
VCbacked
Log inGet Started

Kinoxis Therapeutics

Melbourne, Australia

Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.

$9.5M raised
Aug 2024
Series B
BiotechnologyTherapeutics

Top Investors

National Institutes of HealthUniversity of SydneyUniseedStoic VCBrisbane Angels

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kinoxis Therapeutics

How much funding has Kinoxis Therapeutics raised?
Kinoxis Therapeutics has raised $9.5M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
Who are Kinoxis Therapeutics's investors?
Kinoxis Therapeutics's investors include National Institutes of Health, University of Sydney, Uniseed, Stoic VC, Brisbane Angels.
Where is Kinoxis Therapeutics headquartered?
Kinoxis Therapeutics is headquartered in Melbourne, Australia.
What does Kinoxis Therapeutics do?
Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds.
What stage is Kinoxis Therapeutics at?
Kinoxis Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kinoxis Therapeutics — Funding & Investors." VCBacked, August 12, 2024, https://www.vcbacked.co/company/kinoxis-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Kinoxis Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/kinoxis-therapeutics
Wikipedia (cite web)
{{cite web |title=Kinoxis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kinoxis-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong